Zhen‐Huan Hu - Concepedia

Author

Zhen‐Huan Hu

Also Known As

Bonfim, Carmem, Hashmi, Shahrukh K., Horowitz, Mary M., Saber, Wael, Seftel, Matthew, Ustun, Celalettin, Z. Hu, Zhen-Huan Hu, Zhenhuan Hu, Zhen‐Huan Hu

111

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin Dana-Farber Cancer Institute Moffitt Cancer Center The University of Texas MD Anderson Cancer Center Cleveland Clinic

About

Zhen‐Huan Hu is an author at Medical College of Wisconsin specializing in medicine, oncology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	474
2	Blood Transplantation	8	8	390
3	Health Sciences	5	5	279
4	Public Health	3	3	99
5	Cell Biology	1	1	21

Zhen‐Huan Hu

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation R. Coleman Lindsley, Wael Saber, Brenton G. Mar, New England Journal of Medicine	2017	750
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran, Blood Advances	2020	421
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT Corey Cutler, Brent R. Logan, Ryotaro Nakamura, Blood	2014	215
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States Caron A. Jacobson, Frederick L. Locke, Long Ma, Transplantation and Cellular Therapy Real-world EvidenceImmunologyPathologyCell Replacement TherapyImmunotherapy	2022	166
Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research Vikas Gupta, Adriana K. Malone, Parameswaran Hari, Biology of Blood and Marrow Transplantation	2013	143
Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US) Marcelo C. Pasquini, Frederick L. Locke, Alex F. Herrera, Blood	2019	94
Survival following allogeneic transplant in patients with myelofibrosis Krisstina Gowin, Karen K. Ballen, Kwang Woo Ahn, Blood Advances	2020	94
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages Simone Feurstein, Amy M. Trottier, Noel Estrada‐Merly, Blood	2022	86
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry Samantha Jaglowski, Zhen‐Huan Hu, Yiyun Zhang, Blood	2019	78
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome Brian C. Shaffer, Kwang Woo Ahn, Zhen‐Huan Hu, Journal of Clinical Oncology	2016	74

Page 1